Publicaciones en las que colabora con Emilio Pérez Trallero (179)

2021

  1. Diagnostic accuracy of adenosine deaminase for pleural tuberculosis in a low prevalence setting: A machine learning approach within a 7-year prospective multi-center study

    PLoS ONE, Vol. 16, Núm. 11 November

2020

  1. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

  2. The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362

  2. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  3. HTLV testing of solid organ transplant donors

    Clinical Transplantation

  4. HTLV-1 infection in solid organ transplant donors and recipients in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1

2017

  1. Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain

    PLoS ONE, Vol. 12, Núm. 4

  2. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088

  3. Erratum to “IV Spanish Consensus Conference on Helicobacter pylori infection treatment” <(Gastroenterol Hepatol (2016) 39 (697–721)> (Gastroenterologia y Hepatologia (S0210570516300589) (10.1016/j.gastrohep.2016.05.003))

    Gastroenterologia y Hepatologia

  4. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

  5. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

  6. The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study

    Vaccine, Vol. 35, Núm. 39, pp. 5264-5270

  7. Thirty years of human infections caused by Yersinia enterocolitica in northern Spain: 1985-2014

    Epidemiology and Infection, Vol. 145, Núm. 11, pp. 2197-2203

2016

  1. Nocardia donostiensis sp. nov., isolated from human respiratory specimens

    Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology, Vol. 109, Núm. 5, pp. 653-660

  2. Autochthonous Nocardia cerradoensis infection in humans, Spain, 2011 and 2014

    Emerging Infectious Diseases, Vol. 22, Núm. 1, pp. 109-111

  3. Biomarker tools to design clinical vaccines determined from a study of annual listeriosis incidence in northern Spain

    Frontiers in Immunology, Vol. 7, Núm. NOV

  4. High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307

  5. IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori

    Gastroenterologia y Hepatologia

  6. Long-term epidemiology of streptococcus pneumoniae serogroup 6 in a region of southern Europe with special reference to serotype 6E

    PLoS ONE, Vol. 11, Núm. 2